[WEBINAR] Identifying Priorities in Early Stage for Manufacturing Success

[WEBINAR] Identifying Priorities in Early Stage for Manufacturing Success

Learn from the experts how to strategise in early stages to succeed in commercialising cell and gene therapy products
It’s no secret that the road to commercialisation for developers of cell and gene therapies is a complex one. To get ahead, manufacturers need to consider early on how they might manufacture the product at scale in later stages. Often, the decisions made in early stages set a product up for the future success and therefore present an opportunity to accelerate development. 

For this webinar, we have gathered a skilled panel of experts from a range of regulatory, manufacturing and biotech strategy backgrounds, to provide guidance in identifying and prioritising decisions in early stages to ensure success in commercialising cell and gene therapy products. 

The panel discussion will include: 
  • How to work with technology developers and suppliers 
  • Finding the right partners for development and manufacturing 
  • Handling regulatory issues and challenges  
  • Solving the challenges of recruiting and workforce development 
 


DETAILS
  • Date: Thursday 10th June 2021
  • Time: 4.00pm BST  |  11.00am EST  |  8.00am PCT
  • Access: Register your spot for free here

MEET YOUR SPEAKERS
Peter Marks
Director - Center For Biologics Evaluation And Research (CBER) 
FDA
Ryan Saadi
Chairman and Chief Executive Officer
Tevogen Bio
 
Katie Kelleher
Associate Partner
McKinsey & Company
Haro Hartounian
Senior Vice President & General Manager
BioCentriq
 
This webinar is being delivered in partnership with BioCentriq